The Sinopharm COVID-19 vaccine has been rated by the WHO as having a very good safety and efficacy profile, according to the Health Minister.
In a media release, Mr Terrence Deyalsingh sought to response to statements by UNC MP Dr. Roodal Moonilal.
The minister says the Sinopharm vaccine has undergone a rigorous WHO assessment, including on-site inspections of the production facility prior approval for the Emergency Use Listing.
He notes the WHO assessment is the same process used for Pfizer, Moderna, Johnson and Johnson and AstraZeneca COVID-19 vaccines, which all currently have EUL approval.
Furthermore, Mr Deyalsingh says Sinopharm has been authorized for use in 45 jurisdictions and over 65 million doses lhave been administered.
He notes that WHO has confirmed the vaccine as having an estimated efficacy rate of 78.1% for all age groups 18 years and over.